As yet, however, no conclusive evidence has been provided on the prognostic and/or predictive value of ERCC1, RRM1, BRCA1 and less of TYMS, nor has any consensus been reached on how these markers could be used for the routine assessment of NSCLC patients (critically reviewed in [25-28]). This evidence concerns the gene TYMS and non-small cell lung carcinoma.